Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-Spy 1 TRIAL—CALGB 150007/150012, ACRIN 6657
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.39.2779
Full Text
Open PDFAbstract
Available in full text
Date
September 10, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)